Efficacy of Galcanezumab in Patients with Episodic Cluster Headaches and a History of Preventive Treatment Failure

被引：0
|
作者：
Plato, B. M. [1 ]
Andrews, J. [2 ]
Rettiganti, M. [2 ]
Tockhorn-Heidenreich, A. [2 ]
Bardos, J. [2 ]
Wenzel, R. [2 ]
Kuruppu, D. [2 ]
Ambrosini, A. [3 ]
机构：
[1] Norton Neurosci Inst, Louisville, KY USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] IRCCS Neuromed, Headache Clin, Pozzilli, Molise, Italy
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Efficacy of erenumab in subjects with episodic migraine with prior preventive treatment failure(s)
    Paemeleire, Koen
    Broessner, Gregor
    Brandes, Jan
    Klatt, Jan
    Zhang, Feng
    Picard, Hernan
    Mikol, Daniel D.
    Lenz, Robert A.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [22] Efficacy of Erenumab in Subjects with Episodic Migraine with Prior Preventive Treatment Failure(s)
    Goadsby, Peter J.
    Paemeleire, Koen
    Broessner, Gregor
    Brandes, Jan
    Klatt, Jan
    Zhang, Feng
    Picard, Hernan
    Mikol, Daniel
    Lenz, Robert
    CEPHALALGIA, 2017, 37 : 13 - 14
  • [23] Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
    Martin, Vincent
    Samaan, Karen Hamrick
    Aurora, Sheena
    Pearlman, Eric M.
    Zhou, Chunmei
    Li, Xiaoping
    Pallay, Robert
    ADVANCES IN THERAPY, 2020, 37 (05) : 2034 - 2049
  • [24] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 234 - 235
  • [25] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2)
  • [26] Real-world Experience with Galcanezumab for the Preventive Treatment of Cluster Headache
    Cho, S. J.
    Mo, H.
    Moon, H. S.
    Kim, B. K.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1)
  • [27] BUDGET IMPACT ANALYSIS OF GALCANEZUMAB-GNLM FOR THE PREVENTIVE TREATMENT OF PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE IN THE UNITED STATES
    Foster, S. A.
    Milev, S.
    Hoog, M.
    Mason, O.
    Sardesai, A.
    Hasan, A.
    Marrone, C.
    VALUE IN HEALTH, 2019, 22 : S277 - S277
  • [28] Zonisamide as a Preventative Treatment Strategy for Chronic and Episodic Cluster Headaches
    Smirnoff, L.
    Sahai-Srivastava, S.
    HEADACHE, 2018, 58 : 149 - 149
  • [29] Efficacy of galcanezumab in patients with migraine and history of failure to 3-4 preventive medication categories: subgroup analysis from CONQUER study
    Okonkwo, Rose
    Tockhorn-Heidenreich, Antje
    Stroud, Chad
    Paget, Marie-Ange
    Matharu, Manjit S.
    Tassorelli, Cristina
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
  • [30] Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases
    Catarci, T
    Fabbrini, G
    Barbanti, P
    Cerbo, R
    CONFINIA CEPHALALGICA, 1996, 5 (02): : 43 - 49
12345